Limbic

Limbic develops clinical AI tools for mental healthcare providers, offering AI-driven assessments, clinical decision support, and patient support companions. The platform includes Limbic Access for patient intakes and assessments, and Limbic Care for on-demand support. Limbic AI reduces assessment time, wait times, and treatment delays while increasing minority referrals by 29%, doubling recovery rates, and reducing dropout by 23%. The company is the only mental health AI chatbot with Class IIa medical device certification. Founded in 2017 and headquartered in London, United Kingdom, Limbic has raised approximately $14.7M in Series A funding. The company differentiates itself through its proprietary AI layer between users and LLMs, developed by 10 PhDs across medicine, AI, and computational psychiatry, ensuring clinical-grade safety. Published in Nature Medicine, Limbic is HIPAA and GDPR compliant with ISO 27001 certification.